HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma
暂无分享,去创建一个
M. Kersten | W. Stevens | D. de Jong | M. Dreyling | J. Doorduijn | H. Hebart | A. Beeker | R. Fijnheer | M. Chamuleau | K. Linton | H. Visser | K. Bakunina | M. Cuijpers